Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., New Brunswick NJ 08901 USA; Relabeled by: Bryant Ranch Prepack, Inc., Burbank, CA, 91504 USA, NDC: 63629-1088-01.

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine…

Recall #: D-1187-2022
Initiated: June 17, 2022

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Drug →

View my saved recalls

Bryant Ranch Prepack, Inc. recalled Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufa… - a critical-severity action.

Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufa… was recalled by Bryant Ranch Prepack, Inc. in July 20, 2022. Reason: Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine …. Check the official notice for the remedy. Verify recall #D-1187-2022 with the FDA Drug before acting.

The recall

Bryant Ranch Prepack, Inc. issued this critical-severity FDA Drug recall-Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine ….

Critical
severity level: Class I
classification: July 20, 2022
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1187-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

The number of affected units is not disclosed in the agency filing, which is common for drug and food recalls where lot-level tracking supersedes unit counts. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., New Brunswick NJ 08901 USA; Relabeled by: Bryant Ranch Prepack, Inc., Burbank, CA, 91504 USA, NDC: 63629-1088-01.

Reason for recall

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Critical (Class I)
Status	Terminated
Recall number	D-1187-2022
Date reported	July 20, 2022
Date initiated	June 17, 2022
Recalling firm	Bryant Ranch Prepack, Inc.
Firm location	Burbank, CA
Affected scope	Not disclosed
Distribution	Distributed to one wholesaler in AL for further distribution in the US.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-1187-2022) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on July 20, 2022. Severity: Critical. Recall number: D-1187-2022.

Where was the recalled product distributed? ▼

Distribution: Distributed to one wholesaler in AL for further distribution in the US..

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Critical), closest by report date among other firms and states.

MSI Express Inc. Recalls Unilever Food So… 2022-07-20 BMW 2022: FUEL SYSTEM, GASOLINE:FUEL INJE… 2022-07-20 VOLKSWAGEN 2021-2022: BACK OVER PREVENTIO… 2022-07-20 AUDI 2022: SEAT BELTS:PRETENSIONER 2022-07-20

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Draximage MAA (Kit for the preparation of… 2022-07-20 Testosterone Cypionate Injection, USP, 20… 2022-07-20 Alpha Lipoic Acid 25mg/mL, 30mL-vial, Ref… 2022-07-20 Alprostadil/Papaverine/Phentolamine 60mcg… 2022-07-20

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported July 20, 2022. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026